Reminiscences: Robert Katzman and Robert Terry

c e a e a n I first met Bob Katzman in 1972 when I began my eurology residency at the Albert Einstein College of Medcine. Bob was the chairman of the department at that time. e had already become a noted scientist studying brain lectrolytes, hydrocephalus, and cerebrospinal fluid dynamcs. He had recently completed a sabbatical with Anders jorklund studying monoaminergic pathways and neuronal egeneration, a field that was just beginning. I began workng under his guidance as a fellow in 1975. He encouraged e to develop new techniques, and with his help I comleted a mini-sabbatical with Saul Snyder and Ian Creese earning how to perform the then new technique of dopaine receptor binding. I was able to bring these techniques ack to Einstein and collaborated successfully with Bob and aynard Makman, a talented pharmacologist at Albert Eintein. By the mid 1970s, Bob had developed a new interest n dementing disorders. It was this last turn in his career that ould lead him to national and international fame. Early on, ob recognized that dementing disorders would become the ost important disease of aging in the next century. He ecognized that lifespan was increasing and that US demoraphics would result in a much older society. He organized series of grants to study aging including a teaching nursing ome grant and the Bronx Aging Study, a longitudinal study esigned to track the transition from normal aging to deentia in an over-age-75 population. Of note, the Bronx ging Study is still in existence more than 20 years later. When Bob relocated to University of California at San iego in 1984, he developed the Alzheimer’s Disease Reearch Center (ADRC) in collaboration with Bob Terry and reated a hotbed of dementia research in an environment acking dementia research. Numerous junior investigators ere recruited and investigations into the biology, pathohysiology, and clinical correlates of dementia continued to xpand. Bob had one more career change when he become